Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Press/Media
Datasets
Activities
Fellowships, Honors, and Prizes
Search by expertise, name or affiliation
Cell-based therapies in kidney disease
Mark E. Rosenberg
Administration (TMED)
Research output
:
Contribution to journal
›
Article
›
peer-review
19
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Cell-based therapies in kidney disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cell-based
100%
Kidney Disease
100%
Mesenchymal Stem Cells
100%
Cell Infusion
66%
Inflammation
33%
Long-term Safety
33%
Long-term Efficacy
33%
Cell Proliferation
33%
Kidney Transplantation
33%
Allogeneic
33%
Bone Marrow
33%
Immune Function
33%
Cell Survival
33%
Acute Kidney Injury
33%
Beneficial Effects
33%
Human Kidney
33%
Independent Pathway
33%
Medicine and Dentistry
Cell Therapy
100%
Nephropathy
100%
Mesenchymal Stem Cell
100%
Infusion
66%
Cell Survival
33%
Acute Kidney Injury
33%
Immune Function
33%
Kidney Transplantation
33%
Cell Proliferation
33%
Kidney Disorder
33%
Pharmacology, Toxicology and Pharmaceutical Science
Kidney Disease
100%
Acute Kidney Failure
50%
Inflammation
50%
Immunology and Microbiology
Mesenchymal Stem Cell
100%
Cell Proliferation
33%
Cell Survival
33%
Kidney Transplantation
33%